Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase
Catherine Uyttenhove(Ludwig Cancer Research), Luc Pilotte(Ludwig Cancer Research), Ivan Théate(UCLouvain), Vincent Stroobant(Ludwig Cancer Research), Didier Colau(Ludwig Cancer Research), Nicolas Parmentier(Ludwig Cancer Research), Thierry Boon(Ludwig Cancer Research), Benoı̂t J. Van den Eynde(Ludwig Cancer Research)
Cited by 2,287
Abstract
Related Papers
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber et al.|Nature Medicine|1998|1.8k
Inhibition of T Cell Proliferation by Macrophage Tryptophan Catabolism
David H. Munn, Ebrahim Shafizadeh, John T. Attwood et al.|The Journal of Experimental Medicine|1999|1.6k
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
Francesco M. Marincola, Elizabeth M. Jaffee, Daniel J. Hicklin et al.|Advances in immunology|1999|1.2k